文献速递神经创伤神经重症

重型创伤性脑损伤患者接受颅内压监测时脑组织氧监测与结局的相关性

Outcomes associated with brain tissue oxygen monitoring in patients with severe traumatic brain injury undergoing intracranial pressure monitoring.
PubMed 文献 · J Neurosurg · 2021-05-14

基于2013至2017年美国国家创伤数据库,纳入3421例接受颅内压监测的重型创伤性脑损伤患者,其中155例(4.5%)同时放置脑组织氧张力监测,经2:1倾向评分匹配比较显示,脑组织氧监测组院内死亡率低于无氧监测组(23.4% vs 35.4%,OR 0.53,95%CI 0.33-0.85,p=0.007),但非良好出院率两组无显著差异,ICU住院时间和机械通气时间更长。

要点

  • 脑组织氧监测组院内死亡率为23.4%,低于无氧监测组的35.4%(OR 0.53,95%CI 0.33-0.85,p=0.007)。
  • 非良好出院率脑组织氧监测组为47.4%,无氧监测组为56.3%(OR 1.41,95%CI 0.87-2.30,p=0.168),无显著差异。
  • 脑组织氧监测组ICU住院时间和机械通气时间显著更长,总住院时间无差异。

核心结论

  • 在颅内压监测基础上联合脑组织氧张力监测与重型创伤性脑损伤患者较低的院内死亡率相关,该结果支持BOOST 2试验的发现并凸显正在进行的BOOST3试验的重要性。

研究设计与样本

  • 基于2013至2017年美国国家创伤数据库的查询分析,纳入放置脑室外引流或脑实质颅内压监测的重型创伤性脑损伤患者3421例。
  • 按是否放置脑实质脑组织氧张力监测分层,采用2:1倾向评分匹配比较两组结局,并以全队列进行敏感性分析,模型校正年龄、性别、格拉斯哥昏迷评分、损伤严重度评分、低血压、保险、种族和医院教学状态。

主要发现

  • 3421例接受颅内压监测的重型创伤性脑损伤患者中,155例(4.5%)放置了脑组织氧监测。
  • 倾向评分匹配后,无氧监测组死亡率为35.4%,氧监测组为23.4%(OR 0.53,95%CI 0.33-0.85,p=0.007)。
  • 非良好出院率氧监测组为47.4%,无氧监测组为56.3%(OR 1.41,95%CI 0.87-2.30,p=0.168)。
  • 总住院时间无差异,但脑组织氧监测组ICU住院时间和机械通气时间显著更长。
  • 敏感性分析中,脑组织氧监测与死亡率降低相关(OR 0.56,95%CI 0.37-0.84),但与非良好出院率升高相关(OR 1.59,95%CI 1.06-2.40)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Brain tissue oxygen monitoring combined with intracranial pressure (ICP) monitoring in patients with severe traumatic brain injury (sTBI) may confer better outcomes than ICP monitoring alone. The authors sought to investigate this using a national database. METHODS: The National Trauma Data Bank from 2013 to 2017 was queried to identify patients with sTBI who had an external ventricular drain or intraparenchymal ICP monitor placed. Patients were stratified according to the placement of an intraparenchymal brain tissue oxygen tension (PbtO2) monitor, and a 2:1 propensity score matching pair was used to compare outcomes in patients with and those without PbtO2 monitoring. Sensitivity analyses were performed using the entire cohort, and each model was adjusted for age, sex, Glasgow Coma Scale score, Injury Severity Score, presence of hypotension, insurance, race, and hospital teaching status. The primary outcome of interest was in-hospital mortality, and secondary outcomes included ICU length of stay (LOS) and overall LOS. RESULTS: A total of 3421 patients with sTBI who underwent ICP monitoring were identified. Of these, 155 (4.5%) patients had a PbtO2 monitor placed. Among the propensity score-matched patients, mortality occurred in 35.4% of patients without oxygen monitoring and 23.4% of patients with oxygen monitoring (OR 0.53, 95% CI 0.33-0.85; p = 0.007). The unfavorable discharge rates were 56.3% and 47.4%, respectively, in patients with and those without oxygen monitoring (OR 1.41, 95% CI 0.87-2.30; p = 0.168). There was no difference in overall LOS, but patients with PbtO2 monitoring had a significantly longer ICU LOS and duration of mechanical ventilation. In the sensitivity analysis, PbtO2 monitoring was associated with decreased odds of mortality (OR 0.56, 95% CI 0.37-0.84) but higher odds of unfavorable discharge (OR 1.59, 95% CI 1.06-2.40). CONCLUSIONS: When combined with ICP monitoring, PbtO2 monitoring was associated with lower inpatient mortality for patients with sTBI. This supports the findings of the recent Brain Oxygen Optimization in Severe Traumatic Brain Injury phase 2 (BOOST 2) trial and highlights the importance of the ongoing BOOST3 trial.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hoffman H, Abi-Aad K, Bunch KM, et al. Outcomes associated with brain tissue oxygen monitoring in patients with severe traumatic brain injury undergoing intracranial pressure monitoring. J Neurosurg. 2021. PMID: 34852324. doi:10.3171/2020.11.JNS203739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。